Nephro-Urology Monthly

Published by: Kowsar

Recurrent Nephrolithiasis Leading to Renal Failure: A Neglected Primary Hyperparathyroidism

Fatemeh Yaghoubi 1 and Maliheh Yarmohamadi 2 , *
Authors Information
1 Nephrology Research Center, Department of Nephrology, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Internal Medicine, Kowsar Hospital, Semnan University of Medical Sciences, Semnan, Iran
Article information
  • Nephro-Urology Monthly: March 2018, 10 (2); e64318
  • Published Online: February 19, 2018
  • Article Type: Case Report
  • Received: December 25, 2017
  • Accepted: February 3, 2018
  • DOI: 10.5812/numonthly.64318

To Cite: Yaghoubi F, Yarmohamadi M. Recurrent Nephrolithiasis Leading to Renal Failure: A Neglected Primary Hyperparathyroidism, Nephro-Urol Mon. 2018 ;10(2):e64318. doi: 10.5812/numonthly.64318.

Abstract
Copyright: Copyright © 2018, Nephro-Urology Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
References
  • 1. Nasri H, Baradaran A. Long-lasting advanced primary yperparathyroidism associated with end-stage renal failure in a diabetic patient,. Acta Medica Iranica. 2004;42(6):461-6.
  • 2. Rejnmark L, Vestergaard P, Mosekilde L. Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab. 2011;96(8):2377-85. doi: 10.1210/jc.2011-0569. [PubMed: 21646371].
  • 3. Starup-Linde J, Waldhauer E, Rolighed L, Mosekilde L, Vestergaard P. Renal stones and calcifications in patients with primary hyperparathyroidism: associations with biochemical variables. Europ J Endocrinol. 2012;166(6):1093-100. doi: 10.1530/eje-12-0032.
  • 4. Ranabir S, Baruah MP, Devi KR. Nephrolithiasis: Endocrine evaluation. Indian J Endocrinol Metab. 2012;16(2):228-35. doi: 10.4103/2230-8210.93740. [PubMed: 22470859].
  • 5. Lin YT, Jiang JS, Fang YW, Tsai MH. A Case of Solitary Kidney Atrophy Due to Primary Hyperparathyroidism: A Case Report. Medicine (Baltimore). 2016;95(2). e2449. doi: 10.1097/MD.0000000000002449. [PubMed: 26765435].
  • 6. Brardi S. Nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: An update on medical management. Archives Renal Diseases Manag. 2016:13-8. doi: 10.17352/2455-5495.000010.
  • 7. Siddiqui F, Weissman DE. Hypercalcemia of malignancy #151. J Palliat Med. 2010;13(1):77-8. doi: 10.1089/jpm.2010.9894. [PubMed: 20050793].
  • 8. Berger AD, Wu W, Eisner BH, Cooperberg MR, Duh QY, Stoller ML. Patients With Primary Hyperparathyroidism-Why Do Some Form Stones?. J Urol. 2009;181(5):2141-5. doi: 10.1016/j.juro.2009.01.028.
  • 9. Silverberg SJ, Walker MD, Bilezikian JP. Asymptomatic primary hyperparathyroidism. J Clin Densitom. 2013;16(1):14-21. doi: 10.1016/j.jocd.2012.11.005. [PubMed: 23374736].
  • 10. Flint P, Haughey B, Lund V, Niparko K, Robbins J, Thomas R, et al. Cummings Otolaryngology‑Head and Neck Surgery. 3. 5th ed. Miss, USA: Mosby, St. Louis,; 2005.
  • 11. Heath H3, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980;302(4):189-93. doi: 10.1056/NEJM198001243020402. [PubMed: 7350459].
  • 12. Marcos FR, Spada CM, De Souza VC. Da silva selistre l recurrent nephrolithiasis in childhood progressing to end-stage renal disease: Case report. Austin J Nephrol Hypertens. 2015;2(5):1051.
  • 13. Gambaro G, Favaro S, D'Angelo A. Risk for renal failure in nephrolithiasis. Am J Kidney Dis. 2001;37(2):233-43. [PubMed: 11157364].
  • 14. Bartsch D, Nies C, Hasse C, Willuhn J, Rothmund M. Clinical and surgical aspects of double adenoma in patients with primary hyperparathyroidism. Br J Surg. 1995;82(7):926-9.
  • 15. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the fourth international workshop. J Clinical Endocrinol Metabolism. 2014;99(10):3561-9. doi: 10.1210/jc.2014-1413.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader